More questions to ask Theres lots to unpack about GLP-1 coverage
Your body deserves the best!*
A meta-analysis of 5 RCTs 42,43,44,45,46 comprising 7,732 adults with T2DM did not observe any effect on cognition, as measured via mini-mental state examination (MMSE) or Montreal cognitive assessment (MoCA), of GLP-1RAs over several months compared with the baseline 38
Recognizing these signs is the first step in making an informed decision about discontinuing your GLP-1 medication
The research-grade material supplied by Koi Peptides Canada is not authorized under the Food and Drugs Act for use in humans, does not carry a Drug Identification Number (DIN), Natural Product Number (NPN), or Homeopathic Drug Number (DIN-HM) issued by Health Canada, and is not intended to diagnose, treat, cure, or prevent any disease
1996.Characterization, Formulation, and Stability of Neupogen (Filgrastim), a Recombinant Human Granulocyte-Colony Stimulating FactorFormulation, Characterization, and Staibility of Protein Drugs: Case Histories, Plenum Press, New York